Search

The article informs that General Electric Co. (GE) will face a trial on the charges that its drug Omniscan has caused a rare crippling diseases, the drug has been used for enhancing the performance of the magnetic resonance imaging (MRIs) in the U.S. The case will commence from January 17, 2011 at the U.S. District Court in Cleveland, Ohio. Also, GE has constantly supported its drug but opponent claimed that it failed to protect consumers from the drug's side effects.

The article discusses a court case ruling wherein, the U.S. District Judge Dan Polster in Cleveland, Ohio has given plaintiffs' lawyers wide latitude to present evidence and expert testimony that GE Healthcare company's Omniscan imaging drug caused nephrogenic systemic fibrosis (NSF), in magnetic resonance imaging (MRI) patients with kidney problems. Lawyers for NSF victims claim that GE failed to adequately warn doctors and patients about the dangers.